Foresite Capital Opportunity Management V, LLC, 10% Owner at Theseus Pharmaceuticals, Inc. (THRX), bought 1,400,000 shares at $2.97 ($4.2M) on 2023-07-17, disclosed to the SEC on 2023-07-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.97 | 176,550 | $524K | 12.6% |
| 2 | $2.97 | 176,550 | $524K | 12.6% |
| 3 | $2.97 | 523,450 | $1.6M | 37.4% |
| 4 | $2.97 | 523,450 | $1.6M | 37.4% |
| Total | $2.97 avg | 1,400,000 | $4.2M | 100% |
| Filing → |
| PRDS | BUY | 2023-04-06 | $1.2M | — | Filing → |
| THRX | BUY | 2023-01-03 | $1.3M | — | Filing → |
| PRDS | BUY | 2021-12-23 | $3.3M | — | Filing → |